Ping An Healthcare and Technology Company (PIAHY) Fair Value & Analysis
Healthcare · US · Market cap $3.2B
Ping An Healthcare and Technology Company
PIAHY · US
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 6 days ago
Fair value updated Jun 24, 2026 — revised from $1.14 to $1.13 (−0.9%) since Jun 23, 2026. Share price −36.0% over the past month.
Price vs Fair Value (12 months)
12‑month range $3.00 – $8.59 · fair‑value band $1.00 – $1.55 · the $3.00 price screens above the $1.13 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Ping An Healthcare and Technology Company (PIAHY) currently trades at $3.00, while our model-based Fair Value estimate is $1.13 — implying the stock looks roughly 62.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Ping An Healthcare and Technology Company generated revenue of $5.5B at a net margin of 6.9%. Revenue grew 9.3% year over year. It earns a return on equity of 5.6%. The balance sheet holds a net cash position of $2.4B. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in China. It offers online diagnosis and treatment, online consultation services, audio and video consultations, standardized healthcare service packages, health check-ups, genetic testing, concierge services, health management services, smart device sales, and consulting services. The company also provides online consultation, hospital referral and appointment, inpatient arrangement, and second opinion services; prepaid cards and health check-up services. The company online consultation, hospital referral, inpatient arrangement, second opinion services, electronic prescriptions, health management, prepaid packages for healthcare products and services, provision of products in the Group's health mall, advertising services, and consulting services, as well as operates an insurance agency. In addition it is involved in the integrated finance business. The …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ping An Healthcare and Technology Company reported revenue of $5.3B in FY2025 versus $7.3B in FY2021, a compound −7.7%/yr. Reported net income was $369M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $163.76 | $103.58 | -37% |
| Pro Medicus Limited PME | A$172.80 | A$32.25 | -81% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $84.61 | $79.57 | -6% |
| M3, Inc MTHRY | $5.03 | $7.44 | +48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ping An Healthcare and Technology Company (PIAHY) undervalued?
What is the fair value of PIAHY?
What is the quality score of PIAHY?
What is the revenue of Ping An Healthcare and Technology Company (PIAHY)?
What is the net profit margin of PIAHY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.